The misuse of GLP-1 drugs without clinical oversight can lead to severe health complications
Shaver opened his presentation by noting the increasing use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonists (GIP/GLP-1 RAs) in recent years
121,122 Multiple lines of evidences have revealed that IDH1 is overexpressed in numerous cancers and is closely correlated with poor prognoses of patients with non-small cell lung carcinoma (NSCLC), 123 PDAC, 124 or one of several hematological malignancies
CrossRef Prediabetes in a French overseas territory: Clinical Characteristics, Risk Factors, and Implications for type 2 diabetes prevention Ren Bun, Babacar Tounkara, Sbastien Leruste, Laurie Kichenapanaidou, Mathilde Simonson, Christine Kowalczyk, Jean-Marc Franco, Catherine Marimoutou, Estelle Nobcourt Preventive Medicine Reports.2024